Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34


Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device.

Bösche LI, Afshari F, Schöne D, Ewers A, Mügge A, Gotzmann M.

Clin Cardiol. 2015 Dec;38(12):720-4. doi: 10.1002/clc.22478.


Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: insights from spirometry and body plethysmography.

Gotzmann M, Knoop H, Ewers A, Mügge A, Walther JW.

Am Heart J. 2015 Oct;170(4):837-842.e1. doi: 10.1016/j.ahj.2015.07.011.


Second degree AV block and severely impaired contractility in cardiac myxedema: a case report.

Chatzitomaris A, Scheeler M, Gotzmann M, Köditz R, Schildroth J, Knyhala KM, Nicolas V, Heyer C, Mügge A, Klein HH, Dietrich JW.

Thyroid Res. 2015 May 19;8:6. doi: 10.1186/s13044-015-0018-2.


B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.

Gotzmann M, Czauderna A, Aweimer A, Hehnen T, Bösche L, Lind A, Kloppe A, Mügge A, Ewers A.

J Heart Valve Dis. 2014 Sep;23(5):537-44.


The prognostic impact of diastolic dysfunction in patients with chronic heart failure and post-acute myocardial infarction: Can age-stratified E/A ratio alone predict survival?

Rigolli M, Rossi A, Quintana M, Klein AL, Yu CM, Ghio S, Dini FL, Prior D, Troughton RW, Temporelli PL, Poppe KK, Doughty RN, Whalley GA; MeRGE Collaborators..

Int J Cardiol. 2015 Feb 15;181:362-8. doi: 10.1016/j.ijcard.2014.12.051.


Three-year outcomes after transcatheter aortic valve implantation with the CoreValve prosthesis.

Gotzmann M, Czauderna A, Hehnen T, Aweimer A, Lind A, Kloppe A, Bösche L, Mügge A, Ewers A.

Am J Cardiol. 2014 Aug 15;114(4):606-11. doi: 10.1016/j.amjcard.2014.05.043.


Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation.

Nuis RJ, Sinning JM, Rodés-Cabau J, Gotzmann M, van Garsse L, Kefer J, Bosmans J, Yong G, Dager AE, Revilla-Orodea A, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Amat-Santos IJ, López J, Dumont E, van Mieghem N, van Gelder T, van Domburg RT, de Jaegere PP.

Circ Cardiovasc Interv. 2013 Dec;6(6):625-34. doi: 10.1161/CIRCINTERVENTIONS.113.000409.


Left atrial diameter, aortic mean gradient, and hemoglobin for risk stratification in patients undergoing transcatheter aortic valve implantation.

Gotzmann M, Thiessen A, Lindstaedt M, Mügge A, Ewers A.

Clin Cardiol. 2013 Apr;36(4):228-34. doi: 10.1002/clc.22100.


Correlation between total atrial conduction time estimated via tissue Doppler imaging (PA-TDI Interval), structural atrial remodeling and new-onset of atrial fibrillation after cardiac surgery.

Müller P, Hars C, Schiedat F, Bösche LI, Gotzmann M, Strauch J, Dietrich JW, Vogt M, Tannapfel A, Deneke T, Mügge A, Ewers A.

J Cardiovasc Electrophysiol. 2013 Jun;24(6):626-31. doi: 10.1111/jce.12084.


Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry.

Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, Napodano M, Testa L, Lefevre T, Guetta V, Nissen H, Hernández JM, Roy D, Teles RC, Segev A, Dumonteil N, Fiorina C, Gotzmann M, Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R.

Circulation. 2012 Nov 6;126(19):2335-44. doi: 10.1161/CIRCULATIONAHA.112.104505.


Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation.

Gotzmann M, Korten M, Bojara W, Lindstaedt M, Rahlmann P, Mügge A, Ewers A.

Am J Cardiol. 2012 Nov 15;110(10):1500-6. doi: 10.1016/j.amjcard.2012.07.010.


From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation.

Gotzmann M, Lindstaedt M, Mügge A.

Am Heart J. 2012 Jun;163(6):903-11. doi: 10.1016/j.ahj.2012.03.017. Review.


Prognostic implications of left ventricular dilation in patients with nonischemic heart failure: interactions with restrictive filling pattern and mitral regurgitation.

Ghio S, Temporelli PL, Marsan NA, Poppe K, Giannuzzi P, Dini FL, Rossi A, Doughty RN, Whalley G; MeRGE HF collaborators..

Congest Heart Fail. 2012 Jul-Aug;18(4):198-204. doi: 10.1111/j.1751-7133.2011.00281.x.


[Shift work].

Gotzmann M.

Praxis (Bern 1994). 2012 Feb 1;101(3):151-9. doi: 10.1024/1661-8157/a000832. German. No abstract available.


High frequency of diastolic dysfunction in a population-based cohort of elderly women--but poor association with the symptom dyspnea.

Germing A, Gotzmann M, Schikowski T, Vierkötter A, Ranft U, Krämer U, Mügge A.

BMC Geriatr. 2011 Nov 2;11:71. doi: 10.1186/1471-2318-11-71.


Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.

Gotzmann M, Pljakic A, Bojara W, Lindstaedt M, Ewers A, Germing A, Mügge A.

Am Heart J. 2011 Aug;162(2):238-245.e1. doi: 10.1016/j.ahj.2011.05.011.


Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis.

Gotzmann M, Lindstaedt M, Bojara W, Ewers A, Mügge A.

Catheter Cardiovasc Interv. 2012 Apr 1;79(5):693-701. doi: 10.1002/ccd.23240.


Diastolic dysfunction without abnormalities in left atrial and left ventricular geometry does not affect quality of life in elderly women.

Germing A, Gotzmann M, Schikowski T, Vierkötter A, Ranft U, Mügge A.

Exp Clin Cardiol. 2011 Summer;16(2):37-9.


Fatal prosthetic valve endocarditis of the CoreValve ReValving System.

Gotzmann M, Mügge A.

Clin Res Cardiol. 2011 Aug;100(8):715-7. doi: 10.1007/s00392-011-0315-2. No abstract available.

Items per page

Supplemental Content

Loading ...
Support Center